NYKODE THERAPEUTICS ASANYKODE THERAPEUTICS ASANYKODE THERAPEUTICS ASA

NYKODE THERAPEUTICS ASA

No trades
See on Supercharts

Price target

0.770.000.00%
The 5 analysts offering 1 year price forecasts for 5VB have a max estimate of — and a min estimate of —.

Analyst rating

Based on 5 analysts giving stock ratings to 5VB in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


5VB EPS for the last quarter is −0.04 EUR despite the estimation of −0.04 EUR. In the next quarter EPS is expected to reach −0.05 EUR. Track more of NYKODE THERAPEUTICS ASA financials and stay on top of what is up with the company.
In the next quarter NYKODE THERAPEUTICS ASA revenue is expected to reach ‪1.28 M‬ EUR. Check out NYKODE THERAPEUTICS ASA revenue and earnings and make informed decisions.
According to analysts, 5VB price target is 0.77 EUR with a max estimate of 2.13 EUR and a min estimate of 0.22 EUR. Check if this forecast comes true in a year, meanwhile watch NYKODE THERAPEUTICS ASA stock price chart and keep track of the current situation with 5VB news and stock market news.
We've gathered opinions of 5 analysts rating 5VB stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.